Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy & Immunology
Verus Pharmaceuticals reports study supporting two doses of epinephrine for anaphylaxis
April 11th, 2006
Verus Pharmaceuticals, Inc., a pediatric-oriented specialty pharmaceutical company, announced study results supporting the potential need for two doses of epinephrine to treat anaphylaxis, a severe, life-threatening systemic allergic reaction. The study, "Factors Affecting the Use of Automatic Epinephrine Injectors," was presented as a poster session at the 2006 American Academy of Allergy, Asthma & Immunology Annual Meeting. According to the 100-person study, one-third of patients experiencing an anaphylactic episode in the field required two epinephrine injections and 50% treated in an urgent care facility required two injections. Importantly, only 16% carried two...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
